Tom Fite Paine
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tom Fite Paine.
Annals of Internal Medicine | 1950
Tom Fite Paine; Roderick Murray; Irwin Perlmutter; Maxwell Finland
Excerpt The role of the pleuropneumonia group of microorganisms as human pathogens is still far from clear. In the case reported here a pleuropneumonia-like organism was repeatedly cultured from th...
The American Journal of Medicine | 1947
H. William Harris; Roderick Murray; Tom Fite Paine; Lawrence Kilham; Maxwell Finland
T HERE are a number of reports on the streptomycin treatment of urinary tract infections caused by susceptible gram-negative organisms.‘-9 The clinical results have been quite variable. Some authors have advocated alkalinization of the urine during streptomycin therapy,8~10*11 but to date there have been no convincing data to indicate that the clinical results of streptomycin therapy are favorably influenced by alkalinization of the urine. The purpose of this report is to present clinical and bacteriological observations in twentyone streptomycin-treated patients with urinary tract infections, of whom fourteen were also treated with alkalis.
Annals of Internal Medicine | 1948
Harvey Shields Collins; Tom Fite Paine; Edward Buist Wells; Maxwell Finland
Excerpt There has been a notable lack of success in the treatment of typhoid fever and salmonella infections with the chemotherapeutic and antibiotic agents that are now available. This has been tr...
Annals of Internal Medicine | 1947
Tom Fite Paine; Roderick Murray; Albert O. Seeler; Maxwell Finland
Excerpt Cases of meningitis due toMycobacterium tuberculosisor to gram-negative bacilli are not particularly frequent. They are nevertheless of great importance because of their high mortality and ...
Experimental Biology and Medicine | 1948
Harvey Shields Collins; Edward Buist Wells; Tom Fite Paine; Maxwell Finland
Summary After a single oral dose of 0.5 or 0.75 g of aureomycin given to fasting normal subjects antibiotic activity was recovered in the urine for more than 33 to 55 hours. The antibiotic was excreted in high concentrations between 2 and 16 hours and the largest rate of excretion occurred between 2 and 8 hours. The findings suggest that the optimum intervals between oral doses of aureomycin should be about 8 hours.
JAMA | 1948
Maxwell Finland; Harvey Shields Collins; Tom Fite Paine
Journal of Bacteriology | 1948
Tom Fite Paine; Maxwell Finland
Science | 1948
Tom Fite Paine; Maxwell Finland
The New England Journal of Medicine | 1947
H. William Harris; Roderick Murray; Tom Fite Paine; Maxwell Finland
The New England Journal of Medicine | 1947
Tom Fite Paine; Roderick Murray; Maxwell Finland